Lipid Lowering Therapy, an essential aspect of cardiovascular care, is designed to address and control elevated cholesterol and triglyceride levels within the bloodstream. By employing various medications like statins, fibrates, or cholesterol absorption inhibitors, this therapeutic approach aims to bring about a significant reduction in lipid levels, thereby reducing the risk of cardiovascular diseases, including heart attacks and strokes. The significance of Lipid Lowering Therapy lies in its ability to curtail one of the primary risk factors associated with cardiovascular complications. Regular monitoring of lipid levels and the implementation of personalized treatment plans are key elements in ensuring the effectiveness of Lipid Lowering Therapy. Healthcare professionals tailor interventions based on individual patient profiles, considering factors such as age, medical history, and existing conditions. This personalized approach enhances the precision and success of the therapy, emphasizing its role in holistic cardiovascular management.
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom